Literature DB >> 17214368

Expression of Syk in invasive breast cancer: correlation to proliferation and invasiveness.

Katerina Repana1, Konstantinos Papazisis, Periklis Foukas, Rozalia Valeri, Alexandros Kortsaris, Eleni Deligiorgi, Dimitrios Kyriakidis.   

Abstract

BACKGROUND: Spleen tyrosine kinase (Syk) kinase has recently been considered as a tumor suppressor gene in breast cancer.
MATERIALS AND METHODS: Syk expression in patients with invasive breast cancer was immunohistochemically assessed.
RESULTS: Decreased expression was found in 26% of the specimens examined. In cases with vascular invasion, expression of Syk was lost in the intravascular emboli. A significant relationship between increased proliferation levels (as estimated by the proliferative index, Ki67) and decreased Syk expression (p <0.05) was found.
CONCLUSION: Our data suggest that Syk protein expression inversely correlates with the proliferation and invasive capacity of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17214368

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion.

Authors:  Tracy Layton; Cristel Stalens; Felizza Gunderson; Steve Goodison; Steve Silletti
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

2.  Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells.

Authors:  Xiaoying Zhang; Ulka Shrikhande; Bethany M Alicie; Qing Zhou; Robert L Geahlen
Journal:  Mol Cancer Res       Date:  2009-05-12       Impact factor: 5.852

3.  Adverse drug reaction prediction using scores produced by large-scale drug-protein target docking on high-performance computing machines.

Authors:  Montiago X LaBute; Xiaohua Zhang; Jason Lenderman; Brian J Bennion; Sergio E Wong; Felice C Lightstone
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

4.  SYK expression level distinguishes control from BRCA1-mutated lymphocytes.

Authors:  Tamar Zahavi; Amir Sonnenblick; Asher Y Salmon; Mali Salmon-Divon; Yael Shimshon; Luna Kadouri; Tamar Peretz
Journal:  Cancer Manag Res       Date:  2018-03-26       Impact factor: 3.989

5.  Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer.

Authors:  Yu Yu; Yohan Suryo Rahmanto; Yao-An Shen; Laura Ardighieri; Ben Davidson; Stephanie Gaillard; Ayse Ayhan; Xu Shi; Jianhua Xuan; Tian-Li Wang; Ie-Ming Shih
Journal:  EBioMedicine       Date:  2019-09-03       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.